Colon capsule endoscopy leading to gastrointestinal stromal tumor (GIST) diagnosis after colonoscopy failure

BMC Research Notes

L. Negreanu²  M. Tomescu¹  A. M. Filimon³  A. Stemate² 

[1] General Surgery Department, University Hospital, Carol Davila University of Medicine Bucharest, Bucharest, Romania;Internal Medicine 2-Gastroenterology Department, University Hospital, Carol Davila University of Medicine Bucharest, 169, Splaiul Independentei Street, Sector 5, Bucharest, Romania;Vascular Surgery Department, University Hospital, Carol Davila University of Medicine Bucharest, V Babes National Institute of Pathology, Bucharest, Romania

关键词: Pillcam colon2;    Capsule endoscopy;    Colonoscopy failure;    Sigmoid colon;    GIST;    Gastrointestinal stromal tumors;   

Others  :  1229572
DOI  :  10.1186/s13104-015-1444-x

 received in 2014-03-15, accepted in 2015-09-11,  发布年份 2015

【 摘 要 】

Background

Gastrointestinal stromal tumors are a subtype of mesenchymal tumors. In recent years a significant progress was made in their diagnosis and treatment which led to significant improvement of their prognosis. Endoscopy remains one of the main diagnostic methods. In the rare instance of colonoscopy failure, different approaches are available: different endoscope, computed tomography colonography, capsule endoscopy, use of an enteroscope.

Case presentation

We present the case of a 75-year-old Caucasian man admitted for abdominal pain, diarrhea and weight loss. Two colonoscopy attempts failed in a different center and a decision to use colon capsule endoscopy was made. This exam revealed a submucosal mass located in the sigmoid colon. Surgery was performed and a local invading gastrointestinal stromal tumor was removed. This is the first image of a colonic gastrointestinal stromal tumor seen on capsule endoscopy.

Conclusion

Colon capsule is a useful diagnostic tool in selected patients after colonoscopy failure or contraindication.

【 授权许可】

   
2015 Stemate et al.

【 图 表 】

Fig.1.

【 参考文献 】

• [1]Mucciarini C, Rossi G, Bertolini F, Valli R, Cirilli C, Rashid I, Marcheselli L, Luppi G, Federico M: Incidence and clinicopathologic features of gastrointestinal stromal tumors. A population-based study. BMC Cancer 2007, 7:230. BioMed Central Full Text
• [2]Beham AW, Schaefer IM, Schüler P, Cameron S, Ghadimi BM: Gastrointestinal stromal tumors. Int J Colorectal Dis 2012, 27(6):689-700.
• [3]Miettinen M, Monihan JM, Sarlomo-Rikala M, et al.: Gastrointestinal stromal tumors/smooth muscle tumors (GISTs) primary in the omentum and mesentery: clinicopathologic and immunohistochemical study of 26 cases. Am J Surg Pathol 1999, 23(9):1109-1118.
• [4]Barros A, Linhares E, Valadão M, Gonçalves R, Vilhena B, Gil C, Ramos C: Extragastrointestinal stromal tumors (EGIST): a series of case reports. Hepatogastroenterology 2011, 58(107–108):865-868.
• [5]Levy AD, Remotti HE, Thompson WM, Sobin LH, Miettinen M: Gastrointestinal stromal tumors: radiologic features with pathologic correlation. Radiographics. 2003, 23:283-304.
• [6]Miettinen M, Lasota J: Gastrointestinal stromal tumors—definition, clinical, histological, immunohistochemical, and molecular genetic features and differential diagnosis. Virchows Arch 2001, 438(1):1-12.
• [7]Dafnis G, Granath F, Påhlman L, Ekbom A, Blomqvist P: Patient factors influencing the completion rate in colonoscopy. Dig Liver Dis. 2005, 37:113-118.
• [8]Spada C, Hassan C, Galmiche JP, Neuhaus H, Dumonceau JM, Adler S, Epstein O, Gay G, Pennazio M, Rex DK, et al.: Colon capsule endoscopy: European Society of Gastrointestinal Endoscopy (ESGE) Guideline. Endoscopy 2012, 44:527-536.
• [9]Triantafyllou K, Viazis N, Tsibouris P, Zacharakis G, Kalantzis C, Karamanolis DG, Ladas SD: Colon capsule endoscopy is feasible to perform after incomplete colonoscopy and guides further workup in clinical practice. Gastrointest Endosc 2013, 79(2):307-316.
• [10]Negreanu L, Babiuc R, Bengus A, Sadagurschi R: PillCam Colon 2 capsule in patients unable or unwilling to undergo colonoscopy. World J Gastrointest Endosc. 2013, 5(11):559-567.
• [11]Pioche M, de Leusse A, Filoche B, Dalbiès PA, Adenis Lamarre P, Jacob P, Gaudin JL, Coulom P, Letard JC, Borotto E, et al.: Prospective multicenter evaluation of colon capsule examination indicated by colonoscopy failure or anesthesia contraindication. Endoscopy. 2012, 44:911-916.
• [12]Alarcón-Fernández O, Ramos L, Adrián-de-Ganzo Z, Gimeno-García AZ, Nicolás-Pérez D, Jiménez A, Quintero E: Effects of colon capsule endoscopy on medical decision making in patients with incomplete colonoscopies. Clin Gastroenterol Hepatol 2013, 11(5):534-540.e1.
• [13]Miettinen M, El-Rifai W, Leslie H, Sobin L, Lasota J: Evaluation of malignancy and prognosis of gastrointestinal stromal tumours: a review. Hum Pathol 2002, 3:478-483.
• [14]Stamatakos M, Douzinas E, Stefanaki C, Safioleas P, Polyzou E, Levidou G, et al.: Gastrointestinal stromal tumor. World J Surg Oncol 2009, 7(5):61-65. BioMed Central Full Text
• [15]Lopes LF, Bacchi CE: Imatinib treatment for gastrointestinal stromal tumor (GIST). J Cell Mol Med. 2010, 14(1–2):42-50.
• [16]Dematteo RP, Ballman KV, Antonescu CR, et al.: Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial. Lancet. 2009, 373(9669):1097-1104.